Avacta Group (LON:AVCT) Stock Passes Below Two Hundred Day Moving Average – What’s Next?

Avacta Group Plc (LON:AVCTGet Free Report)’s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 54.36 ($0.69) and traded as low as GBX 40 ($0.51). Avacta Group shares last traded at GBX 40 ($0.51), with a volume of 827,085 shares traded.

Avacta Group Stock Performance

The firm has a market capitalization of £151.96 million, a P/E ratio of -5.15 and a beta of 1.12. The company has a current ratio of 1.29, a quick ratio of 4.96 and a debt-to-equity ratio of 52.53. The company has a 50-day moving average of GBX 48 and a 200-day moving average of GBX 54.16.

About Avacta Group

(Get Free Report)

Avacta Therapeutics is a clinical stage biopharmaceutical company challenging current drug delivery methods to expand the utility of highly potent cancer therapeutics.
The Company benefits from a world class research and development facility, team of exceptionally talented scientists and a highly experienced management team with members located in both the London headquarters and the US.

Our proprietary pre|CISION® platform masks toxic warheads by binding them to a short, engineered peptide that is cleavable only by the tumor-specific protease, fibroblast activation protein (FAP).

See Also

Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.